126 related articles for article (PubMed ID: 16797768)
21. Ancrod enhances the thrombolytic effect of streptokinase and urokinase.
Cercek B; Lew AS; Hod H; Yano J; Lewis B; Reddy KN; Ganz W
Thromb Res; 1987 Aug; 47(4):417-26. PubMed ID: 3660351
[TBL] [Abstract][Full Text] [Related]
22. [Thrombolytic activity of terrilytin and its effect on the coagulating system of the blood].
Andreev SV; Kubatiev AA; Iurkov VA; Kol'tsova NL
Biull Eksp Biol Med; 1976 Aug; 82(8):936-7. PubMed ID: 1026291
[TBL] [Abstract][Full Text] [Related]
23. Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy.
Absar S; Nahar K; Kwon YM; Ahsan F
Pharm Res; 2013 Jun; 30(6):1663-76. PubMed ID: 23468049
[TBL] [Abstract][Full Text] [Related]
24. Higher fibrin-binding and thrombolytic properties of single polypeptide chain--high molecular weight urokinase.
Sumi H; Maruyama M; Matsuo O; Mihara H; Toki N
Thromb Haemost; 1982 Jun; 47(3):297. PubMed ID: 7051412
[No Abstract] [Full Text] [Related]
25. A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in vitro and in vivo.
Runge MS; Quertermous T; Zavodny PJ; Love TW; Bode C; Freitag M; Shaw SY; Huang PL; Chou CC; Mullins D
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10337-41. PubMed ID: 1946453
[TBL] [Abstract][Full Text] [Related]
26. Molecular and functional characterization of a Schistosoma bovis annexin: fibrinolytic and anticoagulant activity.
de la Torre-Escudero E; Manzano-Román R; Siles-Lucas M; Pérez-Sánchez R; Moyano JC; Barrera I; Oleaga A
Vet Parasitol; 2012 Feb; 184(1):25-36. PubMed ID: 21889851
[TBL] [Abstract][Full Text] [Related]
27. [Inactivation and stabilization of urokinase fibrinolytic activity in vitro].
Aĭsina RB; Mukhametova LI; Sazonova IIu; Varfolomeev SD
Bioorg Khim; 1998 Jul; 24(7):544-8. PubMed ID: 9749317
[TBL] [Abstract][Full Text] [Related]
28. Spirulan from blue-green algae inhibits fibrin and blood clots: its potent antithrombotic effects.
Choi JH; Kim S; Kim SJ
J Biochem Mol Toxicol; 2015 May; 29(5):240-8. PubMed ID: 25651404
[TBL] [Abstract][Full Text] [Related]
29. Prourokinase-annexin V chimeras. Construction, expression, and characterization of recombinant proteins.
Tait JF; Engelhardt S; Smith C; Fujikawa K
J Biol Chem; 1995 Sep; 270(37):21594-9. PubMed ID: 7665573
[TBL] [Abstract][Full Text] [Related]
30. Molecular cloning, functional characterization and localization of an annexin from a fish gill fluke Microcotyle sebastis (Platyhelminthes: Monogenea).
Choi SH; Kwon SR; Lee EH; Kim KH
Mol Biochem Parasitol; 2009 Jan; 163(1):48-53. PubMed ID: 18955089
[TBL] [Abstract][Full Text] [Related]
31. [A component of earthworm fibrinolytic enzyme having higher thrombolytic activity than total components in vivo].
Zhao XY; Liu ZM; Jing TY; Wu JX; Zhao ZY
Yao Xue Xue Bao; 2006 Nov; 41(11):1068-73. PubMed ID: 17262949
[TBL] [Abstract][Full Text] [Related]
32. Two characteristics of a recombinant fusion protein composed of staphylokinase and hirudin: high thrombus affinity and thrombus-targeting release ofanticoagulant activity.
Yu A; Zhang C; Dong C; Yu H; Zhong G; Wang L; Wu C
Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1955-61. PubMed ID: 19256345
[TBL] [Abstract][Full Text] [Related]
33. In-vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists and thrombolytics on platelet/fibrin-mediated clot dynamics in human whole blood using thrombelastography.
Mousa SA
Blood Coagul Fibrinolysis; 2007 Jan; 18(1):55-60. PubMed ID: 17179828
[TBL] [Abstract][Full Text] [Related]
34. Numerical analysis of forced injection of enzyme during thrombolysis.
Jeong WW; Rhee K
Comput Biol Med; 2007 May; 37(5):655-62. PubMed ID: 16890215
[TBL] [Abstract][Full Text] [Related]
35. Whole blood clot dissolution: in vitro study on the effects of permeation pressure.
Jeong WW; Jang AS; Rhee K
Proc Inst Mech Eng H; 2007 May; 221(4):357-63. PubMed ID: 17605393
[TBL] [Abstract][Full Text] [Related]
36. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
37. Functional properties of a novel mutant of staphylokinase with platelet-targeted fibrinolysis and antiplatelet aggregation activities.
Chen H; Mo W; Zhang Y; Su H; Ma J; Yao R; Zhang S; Ge J; Song H
Eur J Pharmacol; 2007 Jul; 566(1-3):137-44. PubMed ID: 17451675
[TBL] [Abstract][Full Text] [Related]
38. Chemical conjugation of urokinase to magnetic nanoparticles for targeted thrombolysis.
Bi F; Zhang J; Su Y; Tang YC; Liu JN
Biomaterials; 2009 Oct; 30(28):5125-30. PubMed ID: 19560812
[TBL] [Abstract][Full Text] [Related]
39. The role of nitric oxide in aspirin induced thrombolysis in vitro and the purification of aspirin activated nitric oxide synthase from human blood platelets.
Karmohapatra SK; Chakraborty K; Kahn NN; Sinha AK
Am J Hematol; 2007 Nov; 82(11):986-95. PubMed ID: 17636472
[TBL] [Abstract][Full Text] [Related]
40. Anticoagulant and antithrombotic activity of a new peptide pENW (pGlu-Asn-Trp).
Xiong J; Fang W; Fang W; Bai L; Huo J; Kong Y; Yunman L
J Pharm Pharmacol; 2009 Jan; 61(1):89-94. PubMed ID: 19126301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
